Association of age, inflammatory markers and subclinical atherosclerosis in subjects free from cardiovascular disease;Asociación de marcadores inflamatorios y aterosclerosis subclínica en relación con la edad en sujetos sin enfermedad cardiovascular

Medicina Clinica

Volumn 131, Issue 10, 2008, Pages 361-365

  Páramo, José A ^a   Orbe, Josune ^a   Beloqui, Óscar ^b   Colina, Inmaculada ^b   Benito, Alberto ^b   Rodríguez, José A ^a   Díez, Javier ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Aging; Atherosclerosis; Cardiovascular risk; Inflammation

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE; INTERLEUKIN 6; VON WILLEBRAND FACTOR;

ADULT; AGE; AGED; ARTERIAL PRESSURE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; DISEASE PREDISPOSITION; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; INFLAMMATION; MALE; METABOLIC PARAMETERS; MULTIVARIATE ANALYSIS; RISK FACTOR; SEX RATIO; BLOOD;

AGE FACTORS; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; VON WILLEBRAND FACTOR;

EID: 59449092410     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13126139     Document Type: Article

References (38)

1. Marín J. Age-related changes in vascular responses: a review. Mech Ageing Dev 79 (1995) 71-114
2. Lakatta E.G., and Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part II: the aging heart in health: links to heart disease. Circulation 107 (2003) 346-354
3. Hamilton P.K., Lockhart C.J., Quinn C.E., and McVeigh G.E. Arterial stiffness: clinical relevance, measurement and treatment. Clin Sci (Lond) 113 (2007) 157-170
4. Zoungas S., and Asmar R.P. Arterial stiffness and cardiovascular outcome. Clin Exp Pharmacol Physiol 34 (2007) 647-651
5. Hanson G.K., and Inflammation. atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
6. Lowe G.D.O. Inflammatory/hemostatic biomarkers and risks of cardiovascular and non cardiovascular disease. J Thromb Haemost 3 (2005) 1618-1627
7. Wang T.J., Gona P., Larson M.G., Tofler G.H., Levy D., Newton-Cheh C., et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 355 (2006) 2631-2639
8. Thakore A.H., Guo C.Y., Larson M.G., Corey D., Wang T.J., Vasan R.S., et al. Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol 99 (2007) 1598-1602
9. Fernández-Miranda C., and Grupo Multidisciplinario para el Estudio del Riesgo Cardiovascular. Nuevas perspectivas en la medición del riesgo cardiovascular: exploraciones para detectar aterosclerosis subclínica y marcadores de inflamación. Med Clin (Barc) 128 (2007) 344-351
10. Tracy R.P. Emerging relationships of inflammation, cardiovascular disease and chronic diseases of aging. Int J Obes Relat Metabo Disord 27 (2003) S29-S34
11. Kritchevsky S.B., Cesari M., and Pahor M. Inflammatory markers and cardiovascular health in older adults. Cardiovasc Res 66 (2005) 265-275
12. Weverling-Rijnsburger A.W., Blauw G.J., Lagaay A.M., Knook D.L., Meinders A.E., and Westendorp R.G. Total cholesterol and risk of mortality in the oldest old. Lancet 350 (1997) 1119-1123
13. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
14. Weverling-Rijnsburger A.W., Jonkers I.J., Van Exel E., Gussekloo J., and Westendorp R.G. High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age. Arch Intern Med 163 (2003) 1549-1554
15. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., Smith Jr. S.C., and Lenfant C. National Heart, Lung and Blood Institute. Definition of metabolic syndrome. Circulation 109 (2004) 433-438
16. Beloqui O., Páramo J.A., Orbe J., Benito A., Colina I., Monasterio A., et al. Monocyte cyclooxygenase-2 overactivity: a new marker of subclinical atherosclerosis in asymptomatic subjects with cardiovascular risk factors?. Eur Heart J 26 (2005) 153-158
17. Orbe J., Montero I., Rodríguez J.A., Beloqui O., Roncal C., and Páramo J.A. Independent association of matrix metalloproteinase-10, cardiovascular risk factors and subclinical atherosclerosis. J Thromb Haemost 5 (2007) 91-97
18. Fuentes-Arderiu X., Álvarez-Funes V., Coca-Fábregas L., Cruz-Placer M., Díaz-Fernández J., Herrero Bernal P., et al. Multicentre physiological reference values for the concentration of creatininium in plasma and diagnostic specificity of glomerular filtration rate estimated with the MDRD equation. Clin Chem Lab Med 45 (2007) 531-534
19. Mancini G.B., Dahlof B., and Diez J. Surrogate markers for cardiovascular disease: structural markers. Circulation 109 25 Suppl 1 (2004) 22-30
20. Mionamino T., and Komuro I. Vascular cell senescence. Contribution to atherosclerosis. Circ Res 100 (2007) 15-26
21. Harris T.B., Ferrucci L., Tracy R.P., Corti M.C., Wacholder S., Ettinger Jr. W.H., et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106 (1999) 506-512
22. Strandberg T.E., and Tilvis R.S. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol 20 (2000) 1057-1060
23. Volpato S., Guralnik J.M., Ferrucci L., Balfour J., Chaves P., Fried L.P., et al. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation 103 (2001) 947-953
24. Jenny N.S., Tracy R.P., Ogg M.S., Luong le A., Kuller L.H., Arnold A.M., et al. In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol 22 (2002) 2066-2071
25. Folsom A.R., Aleksic N., Catellier D., Juneja H.S., and Wu K.K. C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study. Am Heart J 144 (2002) 233-238
26. Cao J.J., Thach C., Manolio T.A., Psaty B.M., Kuller L.H., Chaves P.H., et al. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation 108 (2003) 166-170
27. Cesari M., Penninx B.W., Newman A.B., Kritchevsky S.B., Nicklas B.J., Sutton-Tyrrell K., et al. Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study). Am J Cardiol 92 (2003) 522-528
28. Zakai N.A., Katz R., Jenny N.S., Psaty B.M., Reiner A.P., Schwartz S.M., et al. Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study. J Thromb Haemost 5 (2007) 1128-1135
29. Páramo J.A., Rodríguez J.A., Orbe J., and Fibrinógeno. Vieja proteína hemostática con nueva función: marcador no invasivo de aterosclerosis subclínica. Med Clin (Barc) 124 (2005) 790-794
30. Keller C.R., Odden M.C., Fried L.F., Newman A.B., Angleman S., Green C.A., et al. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int 71 (2007) 239-244
31. Páramo J.A., Beloqui O., Colina I., Díez J., and Orbe J. Independent association of von Willebrand factor with surrogate markers of atherosclerosis in middle-aged asymptomatic subjects. J Thromb Haemost 3 (2005) 662-664
32. Brüüngaard H., and Pedersen B.K. Age-related inflammatory cytokines and disease. Immunol Alergy Clin North Am 23 (2003) 15-39
33. Páramo J.A., Beloqui O., Roncal C., Benito A., and Orbe J. Validation of plasma fibrinogen as a marker of carotid atherosclerosis in subjects free of clinical cardiovascular disease. Haematologica 89 (2004) 1226-1231
34. Danesh J., Collins R., Appleby P., and Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279 (1998) 1477-1482
35. Mora S., Rifai N., Buring J.E., and Ridker P.M. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events. Circulation 114 (2006) 381-387
36. Cao J.J., Arnold A.M., Manolio T.A., Polak J.F., Psaty B.M., Hirsch C.H., et al. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation 116 (2007) 32-38
37. Makita S., Nakamura M., and Hiramori K. The association of C-reactive protein levels with carotid intima-media complex and plaque formation in the general population. Stroke 36 (2005) 2138-2142
38. Lowe G.D.O. Circulating inflammatory markers and cardiovascular risk: coming of age?. J Thromb Haemost 5 (2007) 1125-1127